Moderna Inc reported 2.78B in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -43.87M 22.58M
Agios Pharmaceuticals AGIO:US $ -86.22M 1960.54M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Amgen AMGN:US $ 464M 1182M
Arrowhead Research ARWR:US $ -29924000 3.11M
Biogen BIIB:US $ 448.5M 38.3M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
Bluebird Bio BLUE:US $ -241.7M 35.89M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Gilead Sciences GILD:US $ 1522M 207M
GlaxoSmithKline GSK:LN 1395M 322M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -80.88M 8.99M
Mirati Therapeutics MRTX:US $ -166.43M 30.75M
Puma Biotechnology PBYI:US $ -5.11M 21.63M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M
Sangamo Biosciences SGMO:US $ -47.17M 1.24M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Seattle Genetics SGEN:US $ -84.58M 36.84M
Ultragenyx Pharmaceutical RARE:US $ -122.43M 13.71M
United Therapeutics UTHR:US $ 172.6M 144.3M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
YTE INCY:US $ 149.46M 95.92M